Announcements Trials
Browse Landscape

Phase

Phase 2 58Phase 1 34Phase 3 24Phase 1/2 13Phase NA 12Phase 4 5Phase EARLY_PHASE1 2Phase 2/3 1

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 5

Conditions

Breast Neoplasms 9Prostatic Neoplasms 6Neoplasms 5Multiple Myeloma 5Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leiomyoma 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Hematologic Neoplasms 2Glioma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Vomiting 1Venous Thromboembolism 1Tuberous Sclerosis 1Thyroid Neoplasms 1Thyroid Diseases 1Thoracic Neoplasms 1Thalassemia 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pulmonary Embolism 1Primary Myelofibrosis 1Post-operative Seroma Formation 1Polycythemia Vera 1Pituitary Neoplasms 1

Interventions

tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Multiple Myeloma × 30 days × Clear all
NCT05201781 2026-06-05

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Janssen Research & Development, LLC

Phase 4 Recruiting
295 enrolled
Plasma cell

Multiple Myeloma

NCT06057402 2026-06-05

MagnetisMM15

Pfizer

Phase 4 Recruiting
80 enrolled
Plasma cell

Multiple Myeloma

NCT07030517 2026-06-05

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

Johnson & Johnson Private Limited

Phase 4 Recruiting
75 enrolled
Plasma cell

Multiple Myeloma

NCT07191379 2026-06-05

SCILLA

Odense University Hospital

Phase 4 Not yet recruiting
50 enrolled
Plasma cell

Multiple Myeloma

NCT07609940 2026-05-27

POPLIN

Regeneron Pharmaceuticals

Phase 4 Not yet recruiting
30 enrolled
Plasma cell

Cytokine Release Syndrome, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡